Showing results (1041-1050 of 1,241) with videos related to
Sort By:
Pageof 125
BMJ (Clinical Research Ed.)|August 2, 2015
Real world effectiveness of warfarin among ischemic stroke patients with atrial fibrillation: observational analysis from Patient-Centered Research into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) studyYing Xian, Jingjing Wu, Emily C O'Brien, et al.Journal of Cardiac Failure|August 30, 2025
Assessing Benefit in Heart Failure Patients with Reduced Ejection Fraction: Analysis of the VICTORIA Trial Using Novel Prognostic Risk StratificationChristopher M O'Connor, Sarah Rathwell, Devan V Mehrotra, et al.Journal of the American College of Cardiology|August 30, 2022
Estimated Long-Term Benefit of Dapagliflozin in Patients With Heart FailureMuthiah Vaduganathan, Brian L Claggett, Pardeep Jhund, et al.JACC. Heart Failure|December 30, 2014
Primary prevention implantable cardioverter-defibrillators and survival in older womenEmily P Zeitler, Anne S Hellkamp, Gregg C Fonarow, et al.Journal of the American Heart Association|February 23, 2024
Cost Effectiveness of Dapagliflozin for Heart Failure Across the Spectrum of Ejection Fraction: An Economic Evaluation Based on Pooled, Individual Participant Data From the DELIVER and DAPA-HF TrialsAnkeet S Bhatt, Muthiah Vaduganathan, Brian L Claggett, et al.JACC. Advances|February 9, 2025
Embracing Generative Artificial Intelligence in Clinical Research and Beyond: Opportunities, Challenges, and SolutionsHenry P Foote, Chuan Hong, Mohd Anwar, et al.Journal of Clinical Epidemiology|October 1, 2020
PCORnet® 2020: current state, accomplishments, and future directionsChristopher B Forrest, Kathleen M McTigue, Adrian F Hernandez, et al.Stroke|September 15, 2016
Hospital Variation in Home-Time After Acute Ischemic Stroke: Insights From the PROSPER Study (Patient-Centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research)Emily C O'Brien, Ying Xian, Haolin Xu, et al.JAMA|October 20, 2020
Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The VITALITY-HFpEF Randomized Clinical TrialPaul W Armstrong, Carolyn S P Lam, Kevin J Anstrom, et al.Journal of the American Society of Nephrology : JASN|June 21, 2020
AKI and Collapsing Glomerulopathy Associated with COVID-19 and APOL 1 High-Risk GenotypeHuijuan Wu, Christopher P Larsen, Cesar F Hernandez-Arroyo, et al.Pageof 125